Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Voyager Therapeutics (VYGR) Consolidated Net Income: 2015-2025

Historic Consolidated Net Income for Voyager Therapeutics (VYGR) over the last 11 years, with Sep 2025 value amounting to -$27.9 million.

  • Voyager Therapeutics' Consolidated Net Income fell 208.40% to -$27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$126.8 million, marking a year-over-year decrease of 589.88%. This contributed to the annual value of -$65.0 million for FY2024, which is 149.12% down from last year.
  • Per Voyager Therapeutics' latest filing, its Consolidated Net Income stood at -$27.9 million for Q3 2025, which was up 16.45% from -$33.4 million recorded in Q2 2025.
  • In the past 5 years, Voyager Therapeutics' Consolidated Net Income registered a high of $124.0 million during Q1 2023, and its lowest value of -$34.5 million during Q4 2024.
  • Over the past 3 years, Voyager Therapeutics' median Consolidated Net Income value was -$22.2 million (recorded in 2023), while the average stood at -$2.3 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first plummeted by 566.69% in 2022, then skyrocketed by 681.85% in 2023.
  • Quarterly analysis of 5 years shows Voyager Therapeutics' Consolidated Net Income stood at $5.1 million in 2021, then crashed by 566.69% to -$23.6 million in 2022, then skyrocketed by 338.86% to $56.4 million in 2023, then slumped by 161.15% to -$34.5 million in 2024, then crashed by 208.40% to -$27.9 million in 2025.
  • Its Consolidated Net Income stands at -$27.9 million for Q3 2025, versus -$33.4 million for Q2 2025 and -$31.0 million for Q1 2025.